Literature DB >> 16765687

Rapid resolution of topiramate-induced angle-closure glaucoma with methylprednisolone and mannitol.

Douglas J Rhee1, Jerome C Ramos-Esteban, Karen S Nipper.   

Abstract

PURPOSE: Topiramate-induced angle-closure glaucoma (TiACG) is believed to be related to its sulfonamide moiety. Although the exact mechanism is unknown, the time course and constellation of symptoms are consistent with a possible inflammatory pathophysiologic condition.
DESIGN: Interventional case report.
METHODS: We report the clinical outcome of a case of TiACG that was associated with an extreme intraocular pressure elevation of >60 mm Hg that was treated with the combination of systemic mannitol and methylprednisolone.
RESULTS: The combination of the two systemic medications resulted in the resolution of the attack with a much more rapid time course than is seen typically for extreme cases of TiACG. Mannitol treatment alone did not lower the intraocular pressure after 90 minutes, although improvement was noted four hours after methylprednisolone.
CONCLUSION: For severe cases of TiACG that are associated with very high intraocular pressures, the combination of mannitol and methylprednisolone can induce a rapid improvement. Inflammation may be a component of TiACG.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16765687     DOI: 10.1016/j.ajo.2006.01.021

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  18 in total

Review 1.  Non-steroidal drug-induced glaucoma.

Authors:  M R Razeghinejad; M J Pro; L J Katz
Journal:  Eye (Lond)       Date:  2011-06-03       Impact factor: 3.775

2.  Ocular adverse effects of common psychotropic agents: a review.

Authors:  M Reza Razeghinejad
Journal:  CNS Drugs       Date:  2010-11       Impact factor: 5.749

3.  A 53-year-old woman with a severe headache, bilateral eye pain, blurred vision, and photophobia.

Authors:  Pedro Barros; Liliana Paris; Joana Martins; Paula Tenedorio
Journal:  Digit J Ophthalmol       Date:  2011-08-28

4.  Bilateral acute retinal necrosis associated with bilateral uveal effusion in an immunocompetent patient: A challenging association.

Authors:  S Bala Murugan; Girish Bharat Velis; Manavi D Sindal
Journal:  Indian J Ophthalmol       Date:  2018-06       Impact factor: 1.848

Review 5.  Bilateral acute angle closure glaucoma and myopic shift by topiramate-induced ciliochoroidal effusion: case report and literature review.

Authors:  Yu-Wen Lan; Jui-Wen Hsieh
Journal:  Int Ophthalmol       Date:  2017-10-24       Impact factor: 2.031

Review 6.  Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.

Authors:  Richard P Shank; Bruce E Maryanoff
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

Review 7.  Psychotropic Drug-Induced Glaucoma: A Practical Guide to Diagnosis and Management.

Authors:  Neeranjali S Jain; Claire W Ruan; Shanil R Dhanji; Richard J Symes
Journal:  CNS Drugs       Date:  2021-02-19       Impact factor: 5.749

8.  Refractory topiramate-induced angle-closure glaucoma in a man: a case report.

Authors:  Matthew C Willett; Deepak P Edward
Journal:  J Med Case Rep       Date:  2011-01-26

9.  Topiramate and the vision: a systematic review.

Authors:  Mohammad-Ali Abtahi; Seyed-Hossein Abtahi; Farhad Fazel; Peyman Roomizadeh; Masoud Etemadifar; Keivan Jenab; Mojtaba Akbari
Journal:  Clin Ophthalmol       Date:  2012-01-12

Review 10.  A review of drug-induced acute angle closure glaucoma for non-ophthalmologists.

Authors:  Elliott Yann Ah-Kee; Eric Egong; Ahad Shafi; Lik Thai Lim; James Li Yim
Journal:  Qatar Med J       Date:  2015-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.